Dermatology · Los Angeles, CA
NPI
1003203233
Since 2015
Specialty
Dermatology
Code 390200000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4733 W Sunset Blvd Fl 3
Los Angeles, CA, 90027
Phone (323) 783-4516
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,226
22 services
Medicare patients, 2024
13
Average age 62
Drug cost, 2024
$506K
2,148 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Gabrielle Brown prescribed most often to Medicare patients was Clobetasol Propionate, with 320 prescriptions and refills. In total Gabrielle Brown wrote 2,148 Medicare prescriptions that cost $506K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-03.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Clobetasol Propionate Generic | 320 | 425 | 176 | $14K |
| Ketoconazole Generic | 184 | 203 | 99 | $3,035 |
| Triamcinolone Acetonide Generic | 128 | 153 | 93 | $2,486 |
| Hydroxyzine Hcl Generic | 114 | 140 | 31 | $808 |
| Hydrocortisone Generic | 107 | 119 | 69 | $2,008 |
| Tacrolimus Generic | 99 | 118 | 65 | $9,478 |
| Fluorouracil Generic | 98 | 98 | 82 | $3,578 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 70 | 87 | 46 | $4,462 |
| Otezla Apremilast | 65 | 65 | Under 11 | $287K |
| Finasteride Generic | 63 | 153 | 17 | $551 |
| Retin-A Tretinoin | 61 | 61 | 37 | $1,854 |
| Metronidazole Generic | 57 | 65 | 26 | $1,061 |
| Minoxidil Generic | 53 | 140 | 14 | $787 |
| Doxycycline Monohydrate Generic | 51 | 70 | 36 | $1,223 |
| Clindamycin Phosphate Generic | 50 | 61 | 29 | $1,562 |
Brand drugs: 204 claims; generic drugs: 1,944 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Gabrielle Brown were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.